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Abstract: Guiera senegalensis (GS) reflects the reduced glucose exposure of erythrocytes over 
a preceding time frame proportional to erythrocyte survival. GS is thus an anti-diabetic function 
of the glucose-time curve, an educationally useful concept to aid teaching and clinical judgment. 
Sixty-one newly diagnosed patients with an average age of 48.2 years and a weight of 64.9 kg 
have participated in the study. Participants were significantly different in their educational, 
socioeconomic levels, and most of them have no family history of diabetes. To evaluate the 
hypoglycemic effect of GS, the patients were divided into four groups (G1, G2, G3, and G4) and 
treated with four different doses of the aqueous extract of the herb ( 0.5, 1, 1.5 and 2 Oz of  GS 
boiled for 10 minutes in 0.5-liter water). The experiment has lasted for five days for each group, 
and the blood glucose level of the patients was checked using GOD–POD method, at fasting 
(FBS), and following two hours after the breakfast (RBS). Another group of 30 patients (control) 
received Douniel drug (5mg/day/person) instead of the GS herb extract and checked for glucose 
level with the same procedure mentioned above. The results revealed that blood glucose level 
(mg/dl) for all patients lowered by 9% after every 24 hours of the treatment and by 35% at the 
end of the treatment. The average fasting and random blood glucose levels were significantly 
(P<0.001) reduced from 326.21 and 322.95 mg/dl at the start of the treatment to 213.57 and 
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202.87 mg/dl sequentially at the end of the treatment. The herb significantly (P<0.001) reduced 
the blood glucose levels, however, with negligible side effects (vomiting on two patients of group 
G4). Similar hypoglycemic effects on random blood sugar for both the herb extract and Daniel 
drugs noticed. However, the average fasting blood glucose level of patients treated with herb 
extract (266.21 mg/dl) was significantly (P<0.001) lower than that of patients treated with the 
Daniel drug (280.47 mg/dl). Accordingly, the action of this herb may be similar to that of Douniel 
drug. However, it might have more prolonged action than Douniel. The study strongly 
recommends GS as a potential herb for the treatment of type II diabetes.  
1.  Introduction 
Diabetes mellitus is a lifelong non-communicable disease (NCD) that affect the metabolism of glucose 
and been characterized by persistent hyperglycemia [1]. There are two types of diabetes; Type 1, which 
characterised by lack of insulin due to the destruction of the beta cells of the pancreas due to an 
autoimmune disease. It affects mainly children and occurs in 5-10% of the diabetic patient [2]. Type 11 
diabetes is characterised by resistance to the action of insulin in the target cells with or without 
deficiency. It affects the majority of patients and occurs due to hereditary and environmental factors [3].  
Recently, diabetes and other NCDs are assuming increasing importance in the developing world. 
According to a recent WHO report, the number of diabetic patients in the developing world in 1995 will 
increase by the year 2025 by more than 3005 (90% are type 11). At the same, the expected rise in Europe 
will be only 44.8%. The factors that contribute to this unprecedented rise are increased prevalence of 
obesity, decreased physical activity, aging populations, and increased reliance on unhealthy, new, or fast 
foods.  
Currently, in Sudan, diabetes is emerging as a disease of significant morbidity and mortality rates 
[4]. Some studies indicate that it is responsible for 10% of hospital admissions and mortality. The few 
and small-scale prevalence studies were done in 1993 indicated a crude prevalence rate of 3.4%. Since 
then, no statistical studies have been done. The rough impression among the professionals is that at least 
there is one diabetic in each Sudanese family. Type 1 is much rarer and constitutes roughly 10% of all 
cases [5]. 
Guirea senegalensis is a member of the Combretaceae family, and it is a small wild shrub of high 
spreading from the base, leaves simple, opposite or sub-opposite, oblong-elliptic 2.5-5 to 1.5-3.5cm, 
black dotted with glands on both surfaces. This plant is abundant on the sandy soil in the semi-desert 
areas of Kordofan, Darfur, Blue Nile, Upper Nile, and the Northern part of Bahr El-Gazal [6]. Recently, 
some workers investigated the therapeutic value of this herb as anti-diabetes [7], as anti-malarial [8], 
and as a detoxifier agent to snake venom [9, 10]. We feel that the results of these studies are encouraging 
that more investigations are justified. Many Sudanese diabetic patients used water extract of G. 
senegalenesis leaves for their diabetes because they see it active, available, and no side effects were 
shown.  
The rationality of the study, some of the diabetic patients use chemical drugs that may lead to side 
effects such as hypoglycemia. Abdominal a beset, skin problems Many of the diabetic patients leave in 
rural areas where they usually go short of their drugs and might face difficulties in traveling to the near 
town to obtain them. Also, the herbal medicines, in general, have more acceptability to them than 
chemicals. Once many of the patients, especially from rural areas of deficient socio-economic status 
and, might not afford the cost of the chemical drugs, its relatively moderate cost. 
In Kordofan, as well as in many regions in Sudan, many people use G. senegalenesis leaves as a 
treatment for diabetes mellitus. However, this use till now is not accompanied by apparent scientific 
approval for how much this herb is useful for diabetic patients. Accordingly, this study represents a first 
step towards using local herbs instead of chemical drugs as a treatment for diabetes. The specific 
objectives of this study were to determine the influence of Gubaish extract water extraction on an in-
vivo study to evaluate its effects on reducing blood glucose compared with Douniel as standard drug.  
2.  Materials and Methods 
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2.1.   Study area and patient’s condition 
This study, including all non-insulin dependent diabetes (type-11) patients who will visit the diabetic 
clinic (Dr. Mohammed Ahmed Omer center or diabetes, Kordofan-Sudan) within four months from the 
start of our study. The total number of registered patients in this centre since its establishment in 2001 
is about 1700. They belong to various tribes and different socio-economic levels and geographical areas. 
Most of them use G.  Senegalese's leaves (GSL) for a long time as a treatment of diabetes along with or 
without chemical drugs. They believe that GSL has a useful role in the treatment of diabetes. Some 
patients rely only on the GSL, and they enjoy a satisfactory control both clinical (i.e., absence of 
symptoms of hyperglycemia such as polyuria, polydipsia) and glycaemic (i.e., they have normal blood 
glucose levels). 
2.2.  Sample selection 
The sample involved all the newly diagnosed diabetic who will visit the diabetic centre within four 
months from the start of the study. Sixty-one (61) diabetic patients; type 11 participated in this study. 
They were divided into four groups and treated with four different doses of G.  Senegalese's leaves of 
water extract. The other 30 patients participated in the Douniel study. 
2.3.  Preparation of Plant material and treatment  
The leaves of G. sengalenesis were collected from Elobeid city (Khor Taghat region) in November 2005 
and dried in the shade. The leaves were coarsely powdered and weighed 0.5, 1.0,1.5, and 2.0 ounces.  
For the treatment, the plant material for each of the four treatments will be boiled within 0.5 litter distill 
water for 10 minutes. Filtered and the supernatant immediately given to fasting patients. Immediately 
the fasten patient will be checked for fasting blood glucose level (mg/dl). After 15 minutes of the 
treatment of herb extract, the patients would take the breakfast. After 2 hours of the breakfast, the 
patients were checked for random blood sugar. For the control, fasting blood glucose levels at the start 
is considered as a control. Also, the chemical drug Douniel treatment was carried out for the comparison. 
2.4.  Evolution of the effectiveness of fasting and random blood glucose 
Glucose kits, florid tube, spectrophotometer, automatic pipette. Disposable plastic tubes and centrifuge 
are laboratory equipment used for testing blood sugar. Accurately, about 2.5cc blood was taken from 
each patient into a fluoride tube. Then, centrifuged for 3 minutes, then about 1 ml of glucose kits was 
transferred into two new centrifuge tubes. One used for instrument calibration. 1 ml of H2O as blank.  
The other one was used for testing the sample approximately10 µmL of blood with the presence of kit 







nCalculatio  …………… (1) 
Standard concentration = mg/dL 
2.5.  Assessment of data collection using the Questionnaire Technique 
To have an idea about the socio-economic aspects of patients who calibrate in this study, a questionnaire 
form was filled, including the following data which are involved; Family history; Age weight; Sex; 
Duration of illness; Level of education, and income. Finally, the use of G. Senegalese's or any other 
herbal as a treatment for diabetes in the study area also considered. 
2.6.  Data analysis 
All data regards the hypoglycaemic effect of G.senegalensis treatments and Douniel were subjected to 
analysis using software SPSS. 
2.7.  Ethical considerations  
5th International Conference on Mathematical Applications in Engineering










Verbal consent was obtained from all the potential participants in our study after a full explanation of 
nature, included objectives and procedures of the study. It was made clear to the participants that their 
participation is voluntary and can quite at any stage of this study.  
3.   Results and discussion 
3.1.  Socio-economic aspects of patient groups 
Table (1) shows five groups of 91 diabetic patients (type 2) who participated in this study. They are of 
different socio-economic levels, belonging to various tribes and originated in different geographical 
regions of North Kordofan state. The percentage of male to female is different from one group to another, 
and in general, 58% of patients are female, and 42% are male. Their average age and weight were 48.4 
years 64.92 kgs, respectively.  
 
Table 1. The sex %, age average and weight of the study groups 
 
Group 
n Sex Age Weight 
 M (%) F (%) Average ± SD Average ± SD 
G1 15 33.33 66.67 43.53±3.83 73.40 ± 8.87 
G2 15 26.67 73.33 40.33±4.76 67.40 ±12.36 
G3 15 60.00 40.00 48.40±4.86 64.92 ±16.98 
G4 16 46.67 53.33 47.06±7.47 54.60 ±8.36 
G5 30 44.83 55.17 47.44±5.30 55.40± 12.50 
Abbreviations: G1, G2, G3, and G4 represent the patient groups classified according to the dose of 
Gabaish treatment with doses of (0.5, 1, 1.5, 2 ounces/day) for five days respectively dependent manner. 
G5: the patient group who used Douniel as a treatment only. Control: patient without treatment.  
 
In Table (2), the results also showed that the duration of illness for most patients was going to be less 
than one month. Only about 27% of groups G1 and G2 patients were ill for more than four weeks; this 
revealed that all the patients were clinically newly diagnosed with type 2 diabetes. 
 
Table 2:  Duration of illness (NIDDM) of patient groups 
  
 Duration of illness as (%) 
Group 3 days - 2 
weeks 






G1 46 27 13 14 
G2 20 53 7 20 
G3 27 66 7 - 
G4 33 60 - 7 
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Figure 1. Family history 
                    FDR*: First-degree relative. 
                      SDR**: Second-degree relatives. 
 
Figure (1) shows that the patient had no complaints of diabetic complications, and they were mostly 
having no history of diabetes in their families. Additionally, the result approved that 75% of the patient 
group are educated, as presented in Table (3). However, they are of various educational levels. The 
university levels represent a lower percentage (6%) of means. 
 










G1: Group 1, G2: Group 2, G3: Group 3, G4: Group 4, and G5: group 5. 
 
Moreover, the result reflects that the educational level for most of the study groups is the primary school 
for G1 (40%), G3 40%, and high secondary school for G2. Moreover, literacy represents 33% in G1, 
27% in G2, and 20% in G3.  On the other hand, uneducated represent a high percentage of G4 (47%) 
and G5 (45%).    
Furthermore, the result revealed that herbal medicines are widely used in the rural community in the 
treatment of diabetes. We found that G. Senegalanesis represent the most used herbal (70%), out of 15 
types of local herbs in the treatment of diabetes. Some peoples use more than one herb as a treatment 
for diabetes mellitus.     
3.2.  The hypoglycemic effect of G. senegalensis on blood glucose level 
Table 4 and Figure 2 were depicted a remarkable decrease in fasting/random (after 2 hours from 
breakfast and herb treatment) blood glucose level (mg/dL) in patients treated with G. senegalensis 
extract compared to 0 levels (blood glucose level before the start of herb treatments). The concentration 
of blood glucose (mg/dL) is lowered by a decreasing rate from the first day of herb treatments up to the 
5th day, the last day of the measurement. The effect of herb treatment on blood glucose level on the first 
day is not significantly different. 
 






G1 - 7 33 40 13 7 
G2 - 7 27 26 33 7 
G3 7 - 20 40 26 7 
G4 - 47 13 13 20 7 
G5 4 45 10 24 13 4 
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Table 4. The effect of G. senegalensis extracts on fasting/random 







    
*** Significant at (P ≤ 0.001) 
 
The blood glucose level (mg/dL) for all patients groups is lowered by about 9 % during every night of 
the treatment, and about 35% during four nights of the treatments.  Average fasting/random blood 
glucose level is reduced from 326.21/322.95 mg/dL to 213.57/202.87 mg/dL, respectively. This 
approved that the water extract of G. senegalensis leaves has a hypoglycemic effect. This herb was 
scientifically (P ≤ 0.001) reduced the blood glucose levels in all herb treatments (0.5, 1.0,1.5, and 2.0 
Oz of herb/0.5 litre of water) and at four nights of the treatments. 
 
Figure 2: The effect of G. senegalensis extract on blood glucose levels  
(Fasting + Random) in type II diabetic patients within five days 
 
This result agreed with the previous findings, which approved the hypoglycemic effect of G. 
senegalensis extracts using animal models [11].  From the results, a significant hypoglycemic effect in 
fasting/random blood glucose level (P≤0.01) begins from the second day. The biochemical action 
mediated the hypoglycemic effect of G. senegalensis leaves extract is still unknown.  However, it may 
have a role similar to a one or more recently identified hypoglycemic mechanisms of some Chinese 
herbs [12] 
• Increasing insulin secretion (ginseng, bitter melon, aloes, biophytum sensitivum); 
Time N Mean FBS (mg/dl) ± SD Mean RBS (mg/dl) ± SD 
Day1  61 326.21± 48.98 (0 level)  322.95±66.529 
Day2 61    291.72±61.69***  290.00±50.39*** 
Day3 61     262.77±50.02***  265.13±51.84*** 
Day4 61     236.79 ±52.43***  241.66±47.62*** 
Day5 61     213.57±46.72***  202.87±50.219*** 
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• Enhancing glucose uptake by adipose and muscle tissues (ginseng, bitter melon, and 
cinnamon); 
• Inhibiting glucose absorption from the intestine (Myrcia and sanzhi); 
• Inhibiting glucose production from hepatocytes (berberine, fenugreek leaves). 
 
Moreover, some of the phenolic acids have been identified in G. Senegalensis extract and other 
medicinal plants [13]. These acids are known for their potential therapeutic uses: anti-bacterial, anti-
viral (HIV-1), anti-mutagenic, and inflammatory [14]. This anti-inflammatory action may improve the 
pancreas function for the release of insulin, enhances the overall metabolism in the body, and 
subsequently increases the uptake of blood glucose by different organs and tissue.  
3.3.  The effect of G. Singleness dosage on blood glucose level of type II diabetic patients 
The effect of G. senegalensis on blood glucose levels in NIDDM patients was examined using four herb 
concentrations (0.5, 1.0, 1.5, and 2.0 ounces) for four patient groups (G1, G2, G3 & G4). In comparison 
to 0 levels, fasting / random blood glucose level was significantly (P < 0.01) reduced with over the total 
mean values for the four concentrations of herb treatment and through 5 days of treatment (Table 5, 
Table 6). The subsequent increase in herb concentration or dose was not accompanied by a subsequent 
decrease in blood glucose levels in both fasting and random states. However, a reversal effect has been 
shown; the average fasting/random blood glucose level was decreased by increasing the herb 
concentration in the treatment. From the result (Table 5) the average fasting/random blood level is 
233.03/241.51 mg/dL and 292.33/281.86 mg/dl for G1 (0.5 oz) and G4 (2.0) treatments, respectively. 
This is thought to be connected to the mode of action of this herb. The hypoglycemic effect of G3 and 
G4 doses were not significantly different from that with Douniel. However, treatments G1 and G2 
treatment have significantly resulted in a hypoglycemic effect greater than the Douniel. This fact 
declared that higher concentrations of Guiera senegalensis water extract reduce the hypoglycemic effect 
of this plant. Accordingly, a lower effective dose from the leaves extract should be determined for the 
proper use of this herb in the treatment of type II diabetic patients. 
 
Table 5. The effect of G. senegalensis concentration on fasting/random 
Blood glucose levels (mg/dl) in comparison to Douniel 
 
Doses  N Mean FBS ±SD Mean RBS ±SD 
Con. 0.5 oz 75 233.03±72.09** 241.51±77.45** 
Con. 1.0 oz 75 250.51±63.80** 261.07 ± 73.55** 
Con. 1.5 oz 75 287.25±50.27 272.49 ± 54.69 
Con. 2.0 oz 80 292.33±54.95 281.86± 55.46 
Douniel 150 280.47±47.35 267.32 ± 48.56 
                                      **Significant at (P ≤ 0.01) 
 
No side effect of G. senegalensis treatment has been observed through all days of the experiment. This 
attributed to the low dosage of herb concentrations used in this experiment. This consistent with a 
previous study approved that the dose of 250 mg/kg/day of the water extract had a minor change in the 
internal organs of Wister albino rats compared to a dose of 500 and 1000 mg/kg/day [15]. However, 
people in the study area use this plant traditionally in the treatment of diabetes. If it would be safe at low 
concentrations, its safety after long term use needs to be approved. According to this result, the water 
extract of G. senegalensis has a hypoglycemic effect and can be used more safely at lower dose 
concentrations. 
3.4.  Comparison between G. senegalensis and Dounil treatments  
In this study, the overall hypoglycemic effect of G. senegalenesis on fasting/random blood glucose 
levels of type II diabetic patients on five days was compared to the overall hypoglycemic effect for 
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patients treated with the standard chemical drug (Douniel). The result (Table 6) revealed that the average 
fasting blood glucose level of patients treated with herb (266.21 mg/dl) is scientifically (P < 0.05) 
different from that for patients treated with douniel drugs only (280.47 mg/dl). Moreover, no significant 
difference in overall random blood glucose levels of patients treated with G. senegalensis extract 
compared to douniel. The effect of G. senegalensis extract on fasting blood glucose level is more 
significant than effect chemical drug; Douniel. This merit of using this herb in the treatment of type II 
diabetes should be verified over a long term study to secure its safety for an extended user level.  
 
Table 6. The average fasting/random blood glucose level (mg/dl) after five days of G. senegalensis 






       
   
                                         FS-1: Fasting, RBS: Random, *Significant at (P< 0.05) 
 
 Comparing the hypoglycaemic effect of G. senegalensis and Douniel during five days of the 
treatment, a unique pattern for such one has been observed (Table 7). The reduction in fasting blood 
glucose level of the patient was more significant in groups received herb treatment than in the group 
treated with the Douniel. The effect in the case of the random state remains more or less similar for both 
treatments. The detailed result has been shown before in comparing the overall effect of herb treatment 
on fasting/random blood glucose levels compared to Douniel (Table 6, Table 7). This indicated that the 
action of the G.senegalensis effect is different from that of Douniel. The cumulative overnight effect in 
the reduction of fasting blood glucose levels after the second day is more significant than Douniel. 
Douniel is a sulphonylurease agent that lowers blood glucose by stimulating insulin release from beta 
cells of islet tissue in the pancreas. Therefore the Douniel action is prolonged to 24 hours [16]. 
Accordingly, the action of this herb may be similar to Douniel drug; however, it may have more 
prolonged action than Douniel. 
 
Table 7. Comparison between G. senegalensis and Douniel effect on blood 
glucose level (mg/dl) through 5 days of treatment 
 
 
Blood glucose level 
(G. senegalensis) (n=61) 
Blood glucose level, 
(Douniel) (n=30) 
FS-  326.21±48.98 322.77±35.415 
1-P 322.95±66.52 317.03±35.025 
2-F 291.72±61.69** 314.33±35.592 
2-P 290.00±50.39** 297.80±31.982** 
3-F  262.77±50.02** 284.27±31.873** 
3-P 265.13±51.84** 268.03±35.598** 
4-F 236.79±52.43** 252.80±25.308** 
4-P 241.66±47.62** 239.13±25.683** 
5-F  213.57±46.72** 228.20±25.882** 
5-P 202.87±50.21** 214.60±26.925** 
  *FS-1: 0 levels, 1-P: 1st day postprandial, 2-F: 2nd day fasting, 3-P: 3rd day  
  postprandial, 4-F: 4th day fasting, and so on. 
 
 Study G. N Mean Std. Deviation 
FS-1 
  
G. Senegalenesis 305 266.21* 65.400 
Douniel 150 280.47 47.346 
RBS 
  
G. Senegalenesis 305 264.52 67.327 
Douniel 150 267.32 48.562 
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4.  Conclusion  
G. senegalensis herb extract significantly reduced blood glucose levels in type II diabetic patients in 
comparison to Douniel drug.  No side effect has seen on patients treated with 0.5,1.0,1.5 Oz doses of 
herb extract. However, two patients (out of 16) have vomited at a dose of 2.0 Oz herb extract. Many 
interlaboratory tests should be conducted to confirm the result of this study; the hypoglycemic effect of 
G senegalensis on the treatment of type II diabetic patients. 
Further studies should be directed on the leaves of G. senegalensis to identify the active ingredients 
that contributed to the hypoglycemic effect. Sudan is very rich in medicinal plants and shrubs. 
Accordingly, a multidiscipline research unit of different specialists (Biologists, Nutritionists, 
Biochemists, Pharmacologists, and Physicians) with a strong financial position should be found to 
explore the medicinal value & safety use of this plant. Health education is essential to aware people in 
a different part of the country about side effects in using traditionally local herb in the treatment of 
certain diseases. More chance should be given to the patients using traditional medicine to discuss their 
experience with different herbal medicine to benefit from the results and experiences. 
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